Industry: Biotechnology Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A French biotechnology company specializing in animal health is mainly engaged in the research and development of rapid molecular diagnosis technology and product manufacturing for pets, horses and ruminants. Based on molecular detection technologies such as isothermal amplification, the company has developed a portable and efficient on-site detection scheme, which can realize pathogen detection and monitoring without laboratory conditions and significantly improve the efficiency of veterinary diagnosis. At the same time, the enterprise has the ability of freeze-drying process and reagent customization, which can provide partners with complete services from research and development to production, and promote the intelligence and rapidity of animal disease prevention and control.
Product introduction:
1. Horse disease detection
Covers a variety of common infectious diseases, such as influenza, viral arteritis, Lyme disease, anaplasmosis and so on. Can directly detect samples on the spot, and is suitable for racecourses, breeding bases and veterinary clinical detection.
2. Pet testing (dogs and cats)
The detection targets include bacteria, viruses and parasitic diseases, such as canine distemper, feline leukemia and Lyme disease. The freeze-drying reaction system is adopted, which has stable storage and simple operation.
3. Detection of ruminants
It is used for the diagnosis of infectious diseases in cattle, sheep, goats and other livestock animals, such as brucellosis, parasitic infection and respiratory tract pathogen detection, so as to realize early identification and isolation.
Cooperation mode:
Seek partners who need molecular diagnostic reagent services in animal industry.